Search

Your search keyword '"Lo Coco, Francesco"' showing total 1,330 results

Search Constraints

Start Over You searched for: Author "Lo Coco, Francesco" Remove constraint Author: "Lo Coco, Francesco"
1,330 results on '"Lo Coco, Francesco"'

Search Results

1. Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

2. Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial

3. Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial

4. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

5. Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants

7. Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies

8. Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia

9. GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

10. Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome

12. Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL

14. Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia

15. Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy

16. Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes

17. Human Chromosome 7: DNA Sequence and Biology

20. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

21. Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells

22. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia

25. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review

26. Supplementary Figure 3 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

27. Supplementary Table 4 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

28. Supplementary Table 2 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

29. Supplementary Figure 2 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

30. Supplementary Figure 1 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

31. Supplementary Table 3 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

32. Supplementary Table 1 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

33. Supplementary Table 5 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

34. Data from Sequential Valproic Acid/All-trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia

35. Supplementary Table 1 from Sequential Valproic Acid/All-trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia

37. Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis

39. The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations

40. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy

42. The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia

47. Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL

48. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer

50. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

Catalog

Books, media, physical & digital resources